Holen Sie sich die Stockscreener-App
1.63
5.23%
-0.09
Handel nachbörslich:
1.69
0.06
+3.68%
Schlusskurs vom Vortag:
$1.72
Offen:
$1.72
24-Stunden-Volumen:
154.56K
Relative Volume:
0.58
Marktkapitalisierung:
$15.65M
Einnahmen:
$755.00K
Nettoeinkommen (Verlust:
$-9.33M
KGV:
-0.2855
EPS:
-5.71
Netto-Cashflow:
$-5.43M
1W Leistung:
+10.88%
1M Leistung:
-21.63%
6M Leistung:
-46.20%
1J Leistung:
-70.38%
1-Tages-Spanne:
$1.58
$1.72
1-Wochen-Bereich:
$1.423
$2.08
52-Wochen-Spanne:
$1.32
$7.659
Mangoceuticals Inc Stock (MGRX) Company Profile
Firmenname
Mangoceuticals Inc
Sektor
Branche
Telefon
(833) 626-4679
Adresse
15110 DALLAS PKWY, SUITE 600, DALLAS
Vergleichen Sie MGRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MGRX
Mangoceuticals Inc
|
1.63 | 15.65M | 755.00K | -9.33M | -5.43M | -5.71 |
|
VEEV
Veeva Systems Inc
|
285.20 | 45.64B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
61.08 | 9.68B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
97.41 | 8.32B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
59.38 | 11.63B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
36.57 | 6.57B | 906.14M | -52.62M | 89.62M | -0.3621 |
Mangoceuticals Inc Aktie (MGRX) Neueste Nachrichten
Is Mangoceuticals Inc. a good long term investmentDynamic profit opportunities - jammulinksnews.com
Mangoceuticals Inc. Stock Analysis and ForecastHigh-impact stock picks - Autocar Professional
What drives Mangoceuticals Inc. stock priceMassive portfolio appreciation - jammulinksnews.com
Why Mangoceuticals Inc. stock attracts strong analyst attentionFree Top-Rated Stock Analysis - Newser
What analysts say about Mangoceuticals Inc. stockHigh-velocity gains - Autocar Professional
MGRX’s Market Whiplash: -74.88% YTD Decline, -16.49% Plunge in 30 Days - investchronicle.com
What institutions are buying Mangoceuticals Inc. stock nowFree Consultation - Newser
Will Mangoceuticals Inc. stock split in the near futureHigh Yield Stock Selection - Newser
Mangoceuticals President Tony Isaac Resigns - MSN
What makes Mangoceuticals Inc. stock price move sharplyTrade Ready Signal - Newser
How Mangoceuticals Inc. stock performs during market volatilityFree Insider Trading Tips - Newser
Mangoceuticals establishes 6% Series B convertible preferred stock By Investing.com - Investing.com Nigeria
Mangoceuticals establishes 6% Series B convertible preferred stock - Investing.com
Xeris Biopharma (NASDAQ:XERS) versus Mangoceuticals (NASDAQ:MGRX) Head to Head Review - Defense World
Mangoceuticals files to sell 4.46M shares of common stock by selling shareholders - MSN
Mangoceuticals president Tony Isaac resigns from board and executive role - Investing.com
MGRX SEC FilingsMangoceuticals, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Mangoceuticals (NASDAQ:MGRX) Trading Up 1.5% – Should You Buy? - Defense World
Mangoceuticals Inc Files For Mixed Shelf Of Up To $150 Million - MarketScreener
Mangoceuticals Strengthens Position with Equity Transactions - TipRanks
Mangoceuticals, Inc. (NASDAQ: MGRX) is a Stock Spotlight on 3/24 - The Globe and Mail
Mangoceuticals Amends Promissory Note with Indigo Capital - TipRanks
Mangoceuticals shares results from field studies on MGX-0024 - Yahoo Finance
Mangoceuticals (NASDAQ:MGRX) Shares Up 11.8% – Should You Buy? - Defense World
Mangoceuticals reports promising antiviral for poultry health By Investing.com - Investing.com Nigeria
Mangoceuticals reports promising antiviral for poultry health - Investing.com
Mangoceuticals’ Patented MGX-0024 Delivers 100% Respiratory - GlobeNewswire
Mangoceuticals’ Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu - The Globe and Mail
Mangoceuticals, Inc. Terminates Agreements with Key Partners - TipRanks
Finanzdaten der Mangoceuticals Inc-Aktie (MGRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.73%
0.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):